OPA Bulletin

  • News for the Week of February 18, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA Consultation Submission on Proposed Changes to OCP Council Governance and Fees
    • ICYMI: COVID-19 Guidance Document for Community Pharmacies
    • National Pharmacist Survey on Opioid Prescribing and Dispensing Practices

    • *New* Wearable Technology
    • Paid Consultations - Opportunities and Timesavers
    • Identifying Drug Interactions

    • Ask the Practice Support Network

    • Planning to Work in Another Province?

    • DDD Notice No. 20029 posted February 12, 2020 Elimination of Red and White Health Card - Posters for Display

  • News for the Week of February 11, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: OPA's Pre-budget Consultation Submission
    • FIP Guidance Resources for Managing Coronavirus in Pharmacy
    • New Awards to Celebrate Leslie Dan Faculty of Pharmacy Alumni
    • University of Waterloo Survey on Readiness to Assess and Prescribe for Minor Ailments
    • ICYMI: Elimination of Red and White Health Cards
    • 2nd Coalition of Pharmacists Caring for Aging Canadians (CPCAC) Scientific Meeting

    • *Free* Methadone, Buprenorphine and the Community
    • Rational Prescribing: Re-Thinking Medications
    • *Free* Assessment and Management of Patients with Migraine

    • Ask the Customer Experience Administration Team

    • Planning to Retire or Moving to Part B?

    • DDD Notice No. 20027 posted February 10, 2020 Trillium Drug Program - New Online Application Form and Guide
    • DDD Notice No. 20028 posted February 11, 2020 Prescription Forgery Alert

    • Drug Shortage / Supply Health System Alert: Dexamethasone, Ranitidine, Tamoxifen February 7, 2020

    • Apotex Inc. Recalls Certain Lots of Diabetes Medication APO-Metformin ER (extended release) 500 mg Tablets

  • News For The Week Of February 4, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Novel Coronavirus (2019-nCoV) Resources
    • Deadline to Apply to Allied Health Professional Development Fund is March 2, 2020

    • Opioid Addictions and Substitution Therapy FREE Live Webinar Series
    • Essential Cannabis Knowledge for Pharmacists Certificate Program
    • Applying NAPRA’s Non-Sterile Compounding Standards into Practice

    • Ask the Practice Support Network

    • Store Owners, Did You Know?

    • DDD Notice No. 20015 Posted February 3, 2020 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification
    • DDD Notice No. 20016 posted February 4, 2020 Prescription Forgery Alert
    • DDD Notice No. 20017 posted February 4, 2020 Prescription Forgery Alert
    • DDD Notice No. 20018 posted February 4, 2020 Prescription Forgery Alert
    • DDD Notice No. 20019 posted February 4, 2020 Prescription Forgery Alert
    • DDD Notice No. 20020 posted February 4, 2020 Prescription Forgery Alert
    • DDD Notice No. 20021 posted February 4, 2020 Prescription Forgery Alert
    • DDD Notice No. 20022 posted February 4, 2020 Prescription Forgery Alert

    • Drug Shortage / Supply Health System Alert: Effient (Prasugrel)

    • Health Product InfoWatch - January 2020

  • News for the Week of January 28, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Ministry of Health Emergency Operations Centre Provides More Resources for Novel Coronavirus (2019-nCoV)
    • Pillar of Pharmacy Award Nominations

    • Certified Diabetes Educator (CDE) Preparation Course
    • Essential Cannabis Knowledge for Pharmacists Certificate Program
    • Methadone, Buprenorphine and the Community

    • Ask the Customer Experience Administration Team

    • Shopping for Auto Insurance?
    • Last Chance to Avoid an Interruption in Your Professional Liability Insurance

    • ODB Formulary – Edition No. 43, Summary of Changes – January 2020

  • News for the Week of January 21, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Last Chance to Have Your Say on Pre-budget Consultations - Complete Our Survey
    • University of Toronto: Class of 2023 White Coat Ceremony
    • Fluwatch - Register to Monitor Flu Activity
    • Clinical Guidelines on Substance Use Disorders in Older Adults from the Canadian Coalition for Seniors' Mental Health
    • Resources from the Ontario Caregiver Organization

    • Methadone, Buprenorphine and the Community
    • Pharmacist Health Coaching – Cardiovascular Program Training Course
    • FAQs and a New Drugs Update on Contraception and Abortion Care

    • Ask the Practice Support Network
    • Looking for Things to Do With the Kids?

    • OPA Pharmacy (Store) Insurance

    • DDD Notice No. 20009 Posted January 16, 2020 Prescription Forgery Alert
    • DDD Notice No. 20010 Posted January 20, 2020 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies
    • DDD Notice No. 20011 Posted January 21, 2020 Prescription Forgery Alert
    • DDD Notice No. 20012 Posted January 21, 2020 Prescription Forgery Alert

    • Pharmascience Inc. recalls one lot of prescription antifungal drug PMS-Nystatin Oral Suspension: Product may pose a choking risk

  • News for the Week of January 14, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: OPA Surveys on Compounding and Pre-Budget Consultations
    • University of Waterloo: Class of 2023 White Coat Ceremony
    • University of Toronto - Last Call for Applications for OPA's Summer Student Position
    • Health Quality Ontario Surgical Site Injections Quality Standard Advisory Committee

    • Methadone, Buprenorphine and the Community
    • Managing Your Pharmacy: The Business Essentials
    • Applying NAPRA’s Non-Sterile Compounding Standards into Practice

    • Ask the Customer Experience and Administration Team
    • Reminder: Drug Information and Resource Centre (DIRC) Closure

    • Are You Financially Protected from a Serious Illness?

    • DDD Notice No. 20006 posted January 10, 2020 Elimination of Red and White Health Cards
    • DDD Notice No. 20007 posted January 13, 2020 Health Network System (HNS) And Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies

    • Drug Shortage / Supply Health System Alert: Raltitrexed 2mg/vial

  • News for the Week of January 7, 2020

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Tools and Resources to Assist Members with NAPRA Model Standards for Pharmacy Compounding of Non-Sterile Preparations
    • Class Action Authorized For People In Canada Who Used ABILIFY® And Experienced Impulse Control Disorders
    • Attention U of T Students - Work for OPA and Help Shape the Future of Pharmacy

    • Delivering a Comprehensive Pharmacy-Based Vaccines Program
    • Collaborating with Family Physicians: The Rx for Success
    • An Update on Direct Oral Anticoagulation

    • Ask the Practice Support Network
    • OPA's 2020 Early Bird Membership Draw Winners

    • Professional Liability Insurance: Mind Your Policy Language

    • DDD Notice No. 20003 posted January 6, 2020 Health Network System (HNS) and Narcotics Monitoring System Outage Notification to Ontario Drug Programs Agencies

  • News for the Week of December 31, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Happy New Year from OPA!
    • HURRY! OPA Membership Expires TODAY

    • REMINDER: Mandatory Cannabis Education Training Due March 2020
    • Applying NAPRA’s Non-Sterile Compounding Standards into Practice
    • Selling What You Can Do for Your Clients Program
    • Medical Devices Training for Pharmacy Technicians

    • Ask the Customer Experience and Administration Team

    • OPA Secure Health Plan: All-in-one healthcare package

  • News for the Week of December 24, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Happy holidays from OPA!
    • Have your say on common (minor) ailments
    • Congratulations pharmacy graduates!

    • Professional Development Clinical Bundle
    • Professional Development Operational Bundle
    • Professional Development Pharmacy Technician Bundle

    • Ask the Practice Support Network
    • Dell’s Biggest Boxing Week Ever
    • OPA Membership Deadline is December 31, 2019

    • What is Critical Illness insurance?

    • Drug Shortage / Supply Health System Alert: Sterile Mineral Oil 100% - 30 ml vial
    • Drug Shortage / Supply Health System Alert: Etoposide and Raltitrexed
    • Drug Shortage / Supply Health System Alert: Raltitrexed 2mg/vial
    • Drug Shortage / Supply Health System Alert: Etoposide

    • DDD Notice No. 19194 Posted December 23, 2019 Executive Officer Notice: Updates to the Ontario Guidelines for Drug Submission and Evaluation
    • DDD Notice No. 19193 posted December 23, 2019 Notice: Amendments to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act and Regulation 935 under the Drug Interchangeability and Dispensing Fee Act to reduce Administrative Burden to Drug • • • Manufacturers and Pharmacies
    • DDD Notice No. 19192 posted December 19, 2019 Drug Submission Notice: New Submission Deadline Time for Multiple Source Products
    • DDD Notice No. 19191 posted December 16, 2019 Notice: Policy for Pharmacy Payments under the Long-Term Care Home Capitation Funding Model, 2020 - UPDATE

    Atoma-brand Diphenhydramine Hydrochloride 2% Anti-Itch Cream - Advisory
    U-Dream herbal sleep-aid products - Advisory
    Important Safety Information on GILENYA (fingolimod) and the Risk of Congenital Malformations - Novartis Pharmaceuticals Canada Inc.
    Health Product InfoWatch - Safety Updates: Polyethylene glycol 3350

  • News for the Week of December 17, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: Vote on Toronto Star Op-ed and Tell Readers Why Pharmacists Should be Allowed to Prescribe for Common Ailments
    • ICYMI: Ministry Announcement Brings Good News for Pharmacy
    • Last Call to Submit Presentation Proposals for 2020 OPA Conference

    • Managing Your Pharmacy: The Business Essentials
    • Collaborating with Family Physicians: The Rx For Success
    • Essential Cannabis Knowledge for Pharmacy Technicians Program

    • Ask the Customer Experience Administration Team
    • Dell’s Biggest Boxing Week Ever
    • OPA Membership Deadline is December 31, 2019

    • Professional Liability Insurance: "Claims Made" Versus "Occurrence"

    • DDD Notice No. 19191 posted December 16, 2019 Notice: Policy for Pharmacy Payments under the Long-Term Care Home Capitation Funding Model, 2020
    • DDD Notice No. 19190 posted December 16, 2019 Notice: Amendments to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act to Improve the Value of Pharmacy Payments
    • DDD Notice No. 19189 posted December 16, 2019 Notice: Amendments to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act and Regulation 935 made under the Drug Interchangeability and Dispensing Fee Act
    • DDD Notice No. 19188 posted December 13, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – December 2019
    • DDD Notice No. 19185 posted December 12, 2019 Prescription Forgery Alert
    • DDD Notice No. 19184 posted December 11, 2019 Prescription Forgery Alert

Back to top